Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
BMJ (Clinical Research Ed.)
|
September 11, 2010
Investigating secondary hyperhidrosis
A N Paisley, H M Buckler
Clinical Endocrinology
|
March 29, 2007
Withdrawal of somatostatin analogue therapy in patients with acromegaly is associated with an increased risk of acute biliary problems
A N Paisley, M E Roberts, P J Trainer
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 2, 2009
Stabilizing effect of exenatide in a patient with C-peptide-negative diabetes mellitus
A N Paisley, M W Savage, P G Wiles
The Journal of Clinical Endocrinology and Metabolism
|
February 26, 2009
A subnormal peak cortisol response to stimulation testing does not predict a subnormal cortisol production rate
A N Paisley, S V Rowles, D Brandon, et al.
European Journal of Endocrinology
|
February 27, 2007
Pegvisomant interference in GH assays results in underestimation of GH levels
A N Paisley, K Hayden, A Ellis, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 25, 2002
A comparison of the Neuropen against standard quantitative sensory-threshold measures for assessing peripheral nerve function
A N Paisley, C A Abbott, C H M van Schie, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 25, 2011
Changes in arterial stiffness but not carotid intimal thickness in acromegaly
A N Paisley, M Banerjee, M Rezai, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 12, 2018
Impact of social deprivation, demographics and centre on HbA<sub>1c</sub> outcomes with continuous subcutaneous insulin infusion
A N Paisley, J Beynon, C Fullwood, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 24, 2006
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly
A N Paisley, C J O'Callaghan, K C Lewandowski, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
BMJ (Clinical Research Ed.)
|
September 11, 2010
Investigating secondary hyperhidrosis
A N Paisley, H M Buckler
Clinical Endocrinology
|
March 29, 2007
Withdrawal of somatostatin analogue therapy in patients with acromegaly is associated with an increased risk of acute biliary problems
A N Paisley, M E Roberts, P J Trainer
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 2, 2009
Stabilizing effect of exenatide in a patient with C-peptide-negative diabetes mellitus
A N Paisley, M W Savage, P G Wiles
The Journal of Clinical Endocrinology and Metabolism
|
February 26, 2009
A subnormal peak cortisol response to stimulation testing does not predict a subnormal cortisol production rate
A N Paisley, S V Rowles, D Brandon, et al.
European Journal of Endocrinology
|
February 27, 2007
Pegvisomant interference in GH assays results in underestimation of GH levels
A N Paisley, K Hayden, A Ellis, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 25, 2002
A comparison of the Neuropen against standard quantitative sensory-threshold measures for assessing peripheral nerve function
A N Paisley, C A Abbott, C H M van Schie, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 25, 2011
Changes in arterial stiffness but not carotid intimal thickness in acromegaly
A N Paisley, M Banerjee, M Rezai, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 12, 2018
Impact of social deprivation, demographics and centre on HbA<sub>1c</sub> outcomes with continuous subcutaneous insulin infusion
A N Paisley, J Beynon, C Fullwood, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 24, 2006
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly
A N Paisley, C J O'Callaghan, K C Lewandowski, et al.
Page
of 1